Bryant, J., Picot, J., Baxter, L., Levitt, G., Sullivan, I. and Clegg, A. (2007) Clinical and cost-effectiveness of cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review. British Journal of Cancer, 96 (2). pp. 226-230. ISSN 0007-0920 (Unpublished)
Bryant, J., Picot, J., Baxter, L., Levitt, G., Sullivan, I. and Clegg, Andrew ORCID: 0000-0001-8938-7819 (2007) Use of cardiac markers to assess the toxic effects of anthracyclines given to children with cancer: a systematic review. European Journal of Cancer, 43 (13). pp. 1959-1966. ISSN 0959-8049
Bryant, J., Picot, J., Levitt, G., Sullivan, I., Baxter, L. and Clegg, Andrew ORCID: 0000-0001-8938-7819 (2007) Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review. Health Technology Assessment, 11 (27). pp. 1-84. ISSN 1366-5278
Cooper, K., Picot, J., Bryant, J. and Clegg, Andrew ORCID: 0000-0001-8938-7819 (2014) Comparative cost-effectiveness models for the treatment of multiple myeloma. International Journal of Technology Assessment in Health Care, 30 (1). pp. 90-97. ISSN 0266-4623
Loveman, Emma, Cooper, Keith, Bryant, Jackie, Colquitt, Jill L., Frampton, Geoff K. and Clegg, Andrew ORCID: 0000-0001-8938-7819 (2012) Dasatinib, high dose imatinib and nilotinib for the treatment of imatinib-resistant chronic myeloid leukaemia: a systematic review and economic evaluation. Health Technology Assessment, 16 . pp. 1-137. ISSN 1366-5278
Takeda, A.L., Jones, J., Loveman, Emma, Tan, S.C. and Clegg, Andrew ORCID: 0000-0001-8938-7819 (2007) The clinical effectiveness and cost-effectiveness of gemcitabine for metastatic breast cancer: a systematic review and economic evaluation. Health Technology Assessment, 11 (19). pp. 1-62. ISSN 1366-5278